Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diphtheria-Tetanus-acellular Pertussis Vaccines”

245 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 245 results

Not applicableStudy completedNCT03973905
What this trial is testing

Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States

Who this might be right for
Whooping Cough
GlaxoSmithKline 290
Large-scale testing (Phase 3)Study completedNCT01353703
What this trial is testing

Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+4 more
GlaxoSmithKline 224
Testing effectiveness (Phase 2)Study completedNCT04886154
What this trial is testing

A Study on the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Adolescents and Adults

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,440
Not applicableStudy completedNCT00297856
What this trial is testing

Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine

Who this might be right for
DiphtheriaTetanusAcellular Pertussis
GlaxoSmithKline 10,000
Early research (Phase 1)Looking for participantsNCT06184542
What this trial is testing

Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine

Who this might be right for
DiphtheriaTetanusPertussis
Institute of Medical Biology, Chinese Academy of Medical Sciences 460
Large-scale testing (Phase 3)Study completedNCT01309646
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 454
Large-scale testing (Phase 3)Study completedNCT01642589
What this trial is testing

Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South Korea

Who this might be right for
MeningitisMeningococcal Disease
Sanofi Pasteur, a Sanofi Company 300
Early research (Phase 1)Study completedNCT02382913
What this trial is testing

Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)

Who this might be right for
Pertussis
Novartis 315
Post-approval studies (Phase 4)Study completedNCT00514059
What this trial is testing

Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Norwegian Institute of Public Health 83
Large-scale testing (Phase 3)Study completedNCT00352963
What this trial is testing

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 480
Testing effectiveness (Phase 2)Study completedNCT04071158
What this trial is testing

A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS

Who this might be right for
Respiratory Tract Infection
Pfizer 713
Large-scale testing (Phase 3)Study completedNCT00258908
What this trial is testing

Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan

Who this might be right for
DiphtheriaTetanusPertussis
Sanofi Pasteur, a Sanofi Company 115
Post-approval studies (Phase 4)Ended earlyNCT03188458
What this trial is testing

Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia

Who this might be right for
Diphtheria-Tetanus-Acellular Pertussis
GlaxoSmithKline 18
Testing effectiveness (Phase 2)Study completedNCT03589768
What this trial is testing

Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants

Who this might be right for
Clostridium Difficile ImmunisationDiphtheriaDiphtheria Immunisation+3 more
National Institute of Allergy and Infectious Diseases (NIAID) 399
Large-scale testing (Phase 3)Study completedNCT00323050
What this trial is testing

Study of a Booster Dose of Hib-MenC Conjugate Vaccine vs Infanrix Hexa When Given to 14 Month Old Subjects

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 468
Post-approval studies (Phase 4)Study completedNCT01629589
What this trial is testing

Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents

Who this might be right for
TetanusDiphtheriaPertussis+1 more
Sanofi Pasteur, a Sanofi Company 423
Large-scale testing (Phase 3)WithdrawnNCT03128489
What this trial is testing

Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants

Who this might be right for
DiphtheriaAcellular PertussisHaemophilus Influenzae Type b+2 more
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT00518180
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents

Who this might be right for
Meningococcal MeningitisHuman Papillomavirus InfectionPertussis+1 more
Novartis Vaccines 1,620
Large-scale testing (Phase 3)Study completedNCT00390910
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of a 10-valent Pneumococcal Conjugate Vaccine in Preterm Infants

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 286
Large-scale testing (Phase 3)Study completedNCT00879827
What this trial is testing

Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants

Who this might be right for
DiphtheriaPoliomyelitisHepatitis B+2 more
GlaxoSmithKline 60
Next Page